Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries
Crossref DOI link: https://doi.org/10.1007/s10198-017-0871-0
Published Online: 2017-03-16
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Angelis, Aris
Lange, Ansgar
Kanavos, Panos
Funding for this research was provided by:
European Commission Seventh Framework Programme (305983)
Text and Data Mining valid from 2017-03-16
Article History
Received: 2 July 2016
Accepted: 17 January 2017
First Online: 16 March 2017